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Abstract
The ManVan commenced service delivery on 1st April 2014 and is the United Kingdom’s first dedicated mobile support service for men 
affected by prostate, testicular, and penile cancer. It is delivered in partnership with Prostate Cancer UK and Movember and fully funded by 
the Movember Foundation. It brings nursing care, counselling for individuals and couples, group support and welfare rights advice, directly 
to men living with prostate, testicular and penile cancer in communities across Wales. The ManVan has travelled extensively across Wales 
during its first year, visiting 94 different locations, across all seven Local Health Board areas.
The first half of the year began with a Roadshow where we welcomed thousands of visitors on board, including men and women worried 
by all sorts of cancer symptoms; their family and friends; health and social care professionals and politicians. The variety of venues the 
ManVan has visited has included hospitals, supermarkets, social clubs, caravan fairs and rugby grounds to help raise awareness of the 
ManVan service and identify potential clients. As expected the greatest proportion of visitors are male, particularly older men. 
In the second half of the year, we focussed on our target audience – men diagnosed with prostate, testicular, or penile cancer and their 
families. Using a targeted approach to urology clinics across NHS Wales, as well as community-based activity encouraging men from 
ethnic minorities to visit, we have now taken on 161 clients, many of whom have received more than one ManVan service, and attended 
on more than one occasion. Most of our clients have prostate cancer, are over the age of 55 years, and are married. Analysis of the 
early data around the clinical and psychosocial benefits of the services offered on the ManVan is positive and the annualised value of 
the benefits obtained for ManVan clients equates to more than £300,000 in this first year. There were 3,319 visitors to the ManVan in 
total during the first year.
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Introduction
About 50 people are diagnosed with cancer in Wales every day with more than 18,000 new cases of cancer diagnosed in 2012 [1]. The 
NHS in Wales currently spends about 7% of its health budget on cancer services [2]. Although this is a greater proportion of the health 
budget than is spent on cancer services in England, demand in Wales is also greater due to higher levels of cancer incidence. In 2011, 
the incidence of all cancers in England (excluding non-melanoma skin cancer) was 392.5 per 100,000 population, compared to a Welsh 
figure of 411.3 [3]. The quality and availability of cancer services across Wales varies considerably; some cancer specialities have excellent 
support services, while others have none. As people are living longer, cancer is increasingly being recognised as a long-term condition. 
Similarly, survivorship is becoming a key issue for patients, policy makers, health and social care practitioners and cancer charities. The 
latest survival figures reveal that approximately 50% of people survive cancer for 10 or more years in England and Wales [4]. As more and 
more people survive, there is a need to explore new models and approaches to care for those living with, and beyond, cancer.
According to the Welsh Cancer Intelligence and Surveillance Unit (2015) [1], there are almost 10,000 men in Wales diagnosed with cancer 
every year and prostate cancer accounts over a quarter of all these new cancers in men. Additionally, more than 500 men die every year from 
prostate cancer in Wales [5]. There are a high number of deprived areas in Wales [6], a tradition amongst some men in deprived areas of 
unhealthy diets and lifestyles [7], and a lack of awareness of key symptoms, issues which add to the reluctance of men to present their health 
problems to a doctor. Men with prostate, testicular and penile cancer are not well served. Inequalities exist between different Local Health 
Boards, especially in rural areas and these inequalities are not limited to clinical treatment. There is often little or no psychosocial support to 
help people cope at home once active cancer treatment has finished. Financial stability, psychological impact and sexual relationships are 
rarely considered, and limited support in these areas has a substantial impact on well-being.
The ManVan
Due to this limited service provision and support, we decided to build a ManVan that was launched on 1 April 2014. The ManVan is the 
United Kingdom’s first dedicated mobile support service for men affected by prostate, testicular, and penile cancer. We know men are 
not always comfortable talking about their worries, so we designed a space specifically with them in mind. The aim of the ManVan is to 
provide a full range of survivorship services in a single vehicle and to take cancer support services to where they are needed most – into 
the heart of Welsh communities. The ManVan has been funded by The Movember Foundation through Prostate Cancer UK for a period 
of three years. 
ManVan staff includes a logistics officer, who drives the vehicle, a number of specialist nurses, a counsellor, and a welfare rights advisor. 
The ManVan brings nursing advice, counselling for individuals and couples, group support and benefits advice directly to men living with 
these cancers to communities across Wales. Specific objectives are as follows:
•	 To	promote	a	meaningful	quality	of	life	for	men	affected	by	prostate,	testicular,	and	penile	cancer	through	the	provision	of	a	suite	of	
survivorship services 
•	 To	improve	knowledge	and	understanding	of	the	consequences/side	effects	of	treatments	
•	 To	manage	better	the	expectations	men	have	after	their	diagnosis	and	treatment
•	 To	increase	access	to	counselling	and	emotional	support	services	to	improve	both	physical	and	mental	well-being	
•	 To	enhance	the	quality	of	life	of	men	surviving	prostate,	testicular	and	penile	cancer	and	their	families,	carers,	and	friends.	
The locations visited by the ManVan are determined by the location of urology clinics and the needs of new and existing clients. 
The ManVan location calendar is published on the Tenovus Cancer Care Website and distributed to a network of local contacts and 
newspapers on a monthly basis. We also distribute leaflets in local communities in places such as general practitioner (GP) surgeries 
and pharmacies, as well as making considerable use of social media, such as Facebook and Twitter, to promote where and when the 
ManVan will be.
Men are able to access the ManVan service in a number of various ways: they can book an appointment through the Tenovus Cancer 
Care Support Line; they can use an automated texting service to arrange a callback, or can simply drop into the ManVan when it is in their 
community. A referral from a healthcare professional is not necessary and every man can access these services for as long as he needs.
Sh
or
t 
Co
m
m
un
ic
at
 io
n
 3 www.ecancer.org
ecancer 2015, 9:603
Methods
Mobile units provide practical, patient-centred solutions to meeting the needs of cancer patients across Wales. Tenovus have been 
modelling this approach since 2009, when we launched a Mobile Cancer Support Unit for chemotherapy in partnership with Velindre 
Cancer Centre in South Wales [8]. The Mobile unit provides easy access to treatment, support and advice in a safe environment that 
is loved by patients and their families. It epitomises a new kind of cancer care allowing a range of services to be provided on board by 
integrating clinical, emotional, financial, practical, and supportive services. 
As part of the ManVan service, we are collecting and analysing data internally about the following: 
1. Visitors: Defined as those dropping in but not using any services. Data are being collected from visitors by the way of a short feedback 
form that will be administered on the ManVan immediately following the visit. Visitor numbers vary considerably depending on the location 
of the ManVan.
2. Patients/Clients: Defined as those using a service. This can be use of a single service or a number of services on an on-going basis. 
Data are collected at baseline using self-complete survey methods that includes sociodemographic data, clinical data, and satisfaction 
data. We are also using a series of psychometric scales to focus on therapeutic outcomes and measures of perceived social support/
self-efficacy/well-being which will normally take place one month after the initial appointment for nursing advice, but more frequently for 
patients using psychological or financial support services. The timing can be adjusted or the frequency increased to take treatment or 
patient availability into account. The ManVan team have capacity to book up to 36 appointments each week with new or existing clients.
The scales used vary dependent on the service(s) received by the patient and include the following:
EPIC-26: The expanded prostate cancer index composite (EPIC) is a comprehensive instrument designed to evaluate patients after 
prostate cancer treatment [9]. EPIC has been validated in men with localised prostate cancer who undergo surgery, external beam 
radiation, or brachytherapy with or without the use of hormonal adjuvants. Every client who has a nursing appointment completes 
one EPIC-26 form on board the ManVan and one after four to six weeks over the phone with a ManVan nurse. All EPIC-26 scores are 
standardised on scale of 0–100 with higher scores representing better health-related quality of life results (HRQLR). All scores are 
grouped according to the five domains of EPIC-26 and one other relating to urinary incontinence, urinary irritative/obstructive, bowel, 
sexual, hormonal and general urinary function.
Session evaluation: The session evaluation questionnaire (SEQ) developed by Stiles (1980) to measure positivity and arousal 
is completed by all clients ‘before’ and ‘after’ their time on the ManVan [10]. The SEQ is a 7-point bipolar adjective scale capturing 
10 recognised dimensions of mood and emotion [11]. Each item is scored from 1 to 7 and inverted as appropriate, with higher scores 
indicating greater positivity or arousal. Scores are calculated as the mean ratings on the appropriate items rather than the mean of 
the item scores so that the final score lies on the same 7-point scale as the individual items, for clearer interpretation. SEQ results are 
measured by visit not by person.
Session impact: In addition to the session evaluation questionnaire, the session impact scale (SIS) measuring depth and smoothness, is 
also completed immediately ‘after’ a client’s time on board the ManVan. The purpose of the SIS is to assess participant’s perception of the 
overall value of the session plus the perception of session ease. It is a 7-point bipolar scale measuring 11 dimensions of overall depth and 
smoothness [12]. A total of 161 clients completed or partly completed the SIS following their time on the ManVan. The most positive score 
a client can give for any of the 11 scale measures is 7 (smoother and with more depth) and the lowest is 1 (rougher and shallower).
CORE-10: CORE-10 is a measure of ‘psychological distress’ used by all Tenovus Cancer Care counsellors [13]. ManVan clients receive a 
CORE-10 form at ‘assessment’, ‘first’, ‘middle’, and ‘discharge’ session so CORE-10 form numbers will rise when clients start receiving their 
third counselling appointment. Items cover anxiety (2 items), depression (2 items), trauma (1 item), physical problems (1 item) functioning 
(3 items – day to day, close relationships, social relationships) and risk to self (1 item) [13]. CORE-10 scores are normally divided into four 
categories, as shown in Table 1.
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Table 1. CORE-10 categories.
Category Score
1 Healthy 0–10
2 Moderate 11–20
3 Moderate severe 21–25
4 Severe 26–40
3. Service activity and performance metrics: Defined as data relating to the ManVan which is monitored on a monthly basis and which 
includes the following:
•	 distances	travelled	and	locations	visited
•	 numbers	and	demographic	data	of	visitors
•	 availability	and	uptake	of	client	appointments	broken	down	by	service,	type	of	cancer,	and	by	demographics
Finally, we are commissioning an independent external evaluation of the overall project which will be conducted by the Welsh Institute of 
Health and Social Care using a mixed methods approach. This aspect of the evaluation will explore the acceptability of the ManVan survivor-
ship service to patients, family members, carers and to health and social care practitioners across Wales and whether the ManVan is a cost-
effective solution that delivers a better experience and quality of care for men with prostate, testicular, and penile cancer across Wales.
Results
The ManVan has travelled extensively across Wales during its first year, visiting a total of 94 different locations, across all seven Health 
Board Areas (see Figure 1). Over the year, we have travelled 10,923 miles using 12,960 litres of fuel. We have welcomed more than 
3,300 visitors on board, including men and women worried by all sorts of cancer symptoms; their family and friends; health and social 
care professionals, and politicians. From Barry Island in South Wales to Bangor in North Wales, the variety of venues the ManVan 
visited has included hospitals, supermarkets, social clubs, caravan fairs, and rugby grounds to help raise awareness of the ManVan 
service and identify potential clients. As expected, the greatest number of visitors has been male, particularly older men.
Using a targeted approach to urology clinics across NHS Wales, as well as community-based activity encouraging men from ethnic 
minorities to visit, we have now taken on 161 clients, many of whom have received more than one ManVan service, and attended on 
more than one occasion. Most of our clients have prostate cancer, are over the age of 55 years, and are married. Analysis of the early 
data around the clinical and psychosocial benefits of the services offered on the ManVan is positive and the annualised value of the 
benefits obtained for ManVan clients have totalled more than £300,000 in this first year. 
Although the total number of unique clients for the year was 161, the total number of ManVan client visits for the year was 266. This illustrates 
that many clients utilised more than one ManVan service and are also being seen on board on more than one occasion. See Figure 2 for the 
number of clients seen on the ManVan every month during the first year.
Most of the ManVan clients are over the age of 55 (89%). The age range is 34–88 years and the mean is 67 years. This is largely due 
to the age of men diagnosed with prostate cancer. The largest numbers of ManVan clients live in the Hywel Dda Health Board area that 
covers West Wales. This is largely due to an effective partnership with urology clinicians at Prince Phillip Hospital in Llanelli who refer 
many of their patients to the ManVan. The ManVan team work closely with urology teams across Wales, the most successful partnerships 
occurring where existing services are under-resourced, and there is a clinician willing to act as an advocate for the service. Over 80% of 
the clients seen on the ManVan in the first year had prostate cancer, 2% had testicular cancer, and 2% had penile cancer. A small number 
of clients had another cancer, such as head and neck cancer or bladder cancer and were seen as they were experiencing issues similar 
to our clients, such as incontinence. The remaining clients are the spouses or carers of clients who have received services. The majority 
of clients we have seen this year normally travel between 11 and 20 miles to receive treatment for their cancer, and the majority have also 
found the reduction in travel and the multi-disciplinary nature of the ManVan to be more convenient or equal in convenience to use than their 
normal cancer care location. In addition, as the ManVan operates a drop-in service so men can re-access support whenever the vehicle 
visits their community.
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Figure 1. Map of Wales with locations visited.
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Figure 2. Total ManVan clients per month, 2014–2015.
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The total number of appointments offered and attended is outlined in Table 2.
Clinical outcomes: EPIC-26
The results in Figure 3 show average scores for 53 clients who completed one EPIC-26 form, together with the 20 clients who completed 
a second form. At the first appointment, clients are scoring best in the bowel domain and worse in the sexual domain.
For this EPIC-26 scale, the averages from the two groups of men are not directly comparable because the number of people completing 
the second form is fewer than for the first form. We will be able to draw firmer conclusions from these data about the progress of ManVan 
clients as the volume of data collected increases over the next two years. However, these early results do demonstrate the degree of impact 
experienced by men undergoing prostate cancer treatment.
Psychometric scales
Session evaluation (SEQ)
While all clients are asked to complete a SEQ form the majority who agree to do so are currently those receiving Welfare Benefits advice. 
A total of 161 clients completed or partly completed a ‘before’ and ‘after’ SEQ on board the ManVan during the year. Tables 3 and 4 total 
average scores for every client and the change between ‘before’ and ‘after’ their time on the ManVan. The results are positive and show an 
overall increase in positivity and arousal (see Table 5).
Table 2. Appointments offered and attended and client profile by month.
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Total
Appointments offered 1 7 22 33 45 53 62 75 57 86 124 105 670
Appointments attended 1 7 20 29 34 42 49 68 49 77 119 96 591
Total clients 1 7 18 31 23 21 35 30 14 22 31 33 266
•	New	clients 1 7 17 28 18 13 21 12 7 12 17 8 161
•	Existing	clients 0 0 1 3 5 8 14 18 7 10 14 25 105
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Figure 3. Average EPIC-26 scores at baseline and follow-up.
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Table 3. Mean positivity and arousal scores before 
and after visiting the ManVan.
Before After
Positivity 4.7 5.0
Arousal 3.6 3.8
Table 4. Mean combined score for positivity and arousal 
before and after visiting the ManVan.
Before After Change
Score 4.2 4.4 0.2
Table 5. Combined SES and SEQ domain scores.
Domain Score after being on the ManVan
Positivity 5.0
Arousal 3.8
Depth 5.4
Smoothness 5.6
Table 6. Mean changes in CORE-10 scores between stages.
Assessment Core-10 First session Core-10 Midpoint Core-10 Discharge CORE-10
19.12 19.84 16.0 9.5
Because each client is asked to complete this form upon arrival and departure the results can be directly correlated with the advice, support 
and information received on board.
Session impact 
The SIS data for the year show similar result on average for both depth and smoothness. Again these early results show an improvement. 
The session evaluation questionnaire and session impact scale are used together to give an overall score for the four domains. When looking 
at the two sets of results, Smoothness scores highest and Arousal lowest. All four domains of mood and emotion are above the halfway score 
of 3.5 which, again, reflects positively on the ManVan.
Core
A total of 22 clients have completed at least 1 CORE-10 form during the year, with 15 of these clients completing at least 2 forms. Table 6 
shows the mean change in scores between stages.
There are at least four CORE-10 forms to complete with each client, and the results above do not represent the final outcome. Results for 
CORE-10 at this stage are not an accurate reflection of the service received on board the ManVan because the ‘full set’ is not complete 
without ‘assessment’, ‘first’, ‘midpoint’, and ‘discharge’ forms.
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Visitors’ views 
I saw the van on the road and thought I’d pop in. The team cleared up my questions and provided me with info that is not easily 
available from elsewhere. 
The best thing about the ManVan was learning about the best ways to check for testicular cancer. 
I’ve had prostate cancer for 3 years and I’ve learned more about it from you in this session than I was ever told at the hospital. 
The visit was excellent. Everyone was professional and approachable. 
My dad has recently been diagnosed with prostate cancer, it’s really early stage and non-aggressive so he’s lucky I guess. Just 
wanted to say thank you, he visited the ManVan, who supported him in getting a test from his GP (who was previously reluctant 
to do so) and then by complete chance were outside the hospital on the day he had his first appointment. Our experience was the 
doctor didn’t really want to discuss the emotional aspect of dad’s diagnosis, the consultation was brief and we came out with no 
more knowledge or plan going forward than when we went in. Thankfully …. The ManVan team spent time with dad and offered 
him ongoing support. I can’t speak highly enough ….. amazing, very knowledgeable, practical and reassuring. It’s good to know 
that there are services available to patients that are as supportive as yours. 
Conclusion
Although there are significant limitations at this stage of the project, including small sample sizes and incomplete data sets, early indications 
are positive that the ManVan is providing a valuable service to men affected by prostate, testicular, and penile cancer across Wales. We are 
committed to providing the ManVan service in this form until at least 31 March 2017. However, the cancer landscape is changing. New models 
of care and after care are required. Cancer is increasingly being recognised as a long-term condition and services need to evolve and adapt to 
this in order to enable people affected by cancer to live a meaningful, quality life. With newly emerging cancer care needs, socio-demographic 
change and financial pressures, providing long-term cancer support services in community settings, particularly ones that are mobile like the 
ManVan, is one way of ensuring we are getting maximum value and impact from our cancer support services. 
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